Benefit-Risk Assessment of Tegaserod in Irritable Bowel Syndrome

Author: Lea R.   Whorwell P.J.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.27, Iss.4, 2004-01, pp. : 229-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract